Ryan Braun sits out with injury

Ryan Braun wasn't in the Milwaukee Brewers' lineup Wednesday afternoon but it wasn't because of the "Outside the Lines" report that he may be facing a suspension for his connection to an anti-aging clinic at the heart of an ongoing performance-enhancing drug scandal, manager Ron Roenicke said.

Roenicke said Wednesday that the Brewers' left fielder was out of his team's lineup due to his sore right thumb, an injury that has nagged him this season. The Brewers lost the game to the A's, 6-1.

Roenicke told reporters that ESPN's report that Major League Baseball will seek to suspend about 20 players, including Braun, connected to the now-shuttered Biogenesis of America clinic "doesn't bother me."

"I don't know what's going on and it's not an issue to me. I really haven't thought about this. Why it came up, I have no idea. But there's no reason for me to think about it any different than I did in spring training," he said.

Braun on Tuesday said, "I've already addressed everything related to the Miami situation."

"I addressed it in spring training. The truth has not changed. I don't know the specifics of the story that came out today, but I've already addressed it. I've commented on it. I'll say nothing further about it," he said.

Tony Bosch, founder of the now-shuttered Miami-area clinic, reached an agreement this week to cooperate with MLB's investigation, two sources told "Outside the Lines," giving MLB the ammunition officials believe they need to suspend the players.

One source familiar with the case said the commissioner's office might seek 100-game suspensions for Alex Rodriguez, Braun and other players, the penalty for a second doping offense. The argument, the source said, is the players' connection to Bosch constitutes one offense, and previous statements to MLB officials denying any such connection or the use of PEDs constitute another.

Braun entered Wednesday's game batting .292 with nine home runs and 35 RBIs.

Information from ESPN's T.J. Quinn and Pedro Gomez and ESPN.com's Mike Fish was used in this report.